Sigyn Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-3.7M | $7.5K |
| FY2019 | — | $-910 | $500 |
| FY2020 | — | $99.2K | $84.4K |
| FY2021 | — | $-264.6K | $341.0K |
| FY2022 | $2.3M | $-1.9M | $8.4K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-3.7M | $7.5K |
| FY2019 | — | $-910 | $500 |
| FY2020 | — | $99.2K | $84.4K |
| FY2021 | — | $-264.6K | $341.0K |
| FY2022 | $2.3M | $-1.9M | $8.4K |